Stoke Therapeutics Inc. (STOK) Files $400M Mixed Shelf

May 20, 2022 4:11 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Stoke Therapeutics Inc. (NASDAQ: STOK) has filed $400,000,000 mixed shelf of: Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings